Amirreza Nasirzadeh

Mr. Amirreza Nasirzadeh

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2024 in BMC Neurology
Verified
Journal Article
Open access
PDF file
ANAmirreza Nasirzadeh
Amirreza Nasirzadeh
MMMohammad Mohammadi
Mohammad Mohammadi
MBMelika Arab Bafrani
Melika Arab Bafrani
AMAynaz Mohammadi
Aynaz Mohammadi
HBHossein Bakhtiari-Dovvombaygi
Hossein Bakhtiari-Dovvombaygi
Multiple sclerosis (MS) is a chronic autoimmune disorder affecting the central nervous system, leading to a range of symptoms that impact physical, psychiatric, and cognitive functions. Cognitive dysfunction is prevalent among patients with MS (pwMS), affecting at least 65% of patients, and includes deficits in processing speed, attention, learning, memory, and executive function. Despite the significant impact on daily life, cognitive impairment in MS patients is often underrecognized in clinical settings. This systematic review and meta-analysis aimed to evaluate cognitive function using the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) battery among pwMS patients and healthy controls (HCs). A comprehensive search of the Web of Science, PubMed, Scopus, and Cochrane Library databases was conducted on January 2024 following the PRISMA guidelines. Eligible studies included peer-reviewed research assessing the validity of the MACFIMS in adult MS patients. Data extraction and quality assessment were performed using standardized tools, and statistical analyses were conducted using R4.2.3. Eight studies met the inclusion criteria, including a total of 1,481 pwMS and 1,072 HCs. The meta-analysis revealed significant cognitive deficits in pwMS patients compared to HCs across all the MACFIMS subtests, including language, spatial processing, new learning and memory, processing speed, and executive function. Processing speed and working memory were the most affected domains, with 36% of pwMS showing impairment on the Symbol Digit Modalities Test (SDMT). Subgroup analyses indicated that the Expanded Disability Status Scale (EDSS) score significantly influenced cognitive impairment, while disease duration had a limited impact. The MACFIMS effectively discriminates between pwMS patients and HCs, demonstrating its validity as a comprehensive cognitive assessment tool for MS. Routine cognitive screening, particularly for processing speed and working memory, is crucial for early detection and intervention. Future research should focus on the sensitivity and specificity of the MACFIMS across diverse MS subtypes and cultural contexts to enhance its global applicability in clinical practice.

29 September 2022 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
RJReza Jahanshahi
Reza Jahanshahi
ANAmirreza Nasirzadeh
Amirreza Nasirzadeh
MFMahan Farzan
Mahan Farzan
Jan DomaradzkiJan Domaradzki
Jan Domaradzki
LJLeila Mahasti Jouybari
Leila Mahasti Jouybari
SBSasan Bahramzadeh
Sasan Bahramzadeh
Background: Rare diseases are a new global health priority, requiring evidence-based estimates of the global prevalence of diseases to inform public policymakers and provide a serious challenge to the healthcare system that must not be ignored. The purpose of this study is to investigate Iranian future healthcare professionals' knowledge and opinions about rare diseases. Results: A total of 6838 students responded to the questionnaire. Nursing and medical students had the highest participation. Almost 85% of participants rated their knowledge about rare diseases as poor or insufficient. While nearly 70 percent of participants took courses about rare diseases at university. Finally, 72.7% of future healthcare professionals did not feel ready to take care of a patient with a rare disease. Conclusion: The present study has indicated a gap in Iranian medical students’ knowledge of rare diseases. The researchers believe that health science policymakers should make a joint effort to improve knowledge about rare diseases. Including courses with regard to rare diseases would be of benefit to future healthcare professionals.

1 April 2020 in Internal Medicine Today
Verified
Journal Article
Closed access
PDF file
SNSamane Najafi
Samane Najafi
MSMoosa Sajjadi
Moosa Sajjadi
ANAmirreza Nasirzadeh
Amirreza Nasirzadeh
HJHossein Jeddi
Hossein Jeddi
Aims Preoperative anxiety could increase postoperative pain, the need for analgesics, and the patientchr('39')s hospital stay. Therefore, this study aimed to evaluate the effect of aromatherapy with rose on preoperative anxiety before abdominal operation. Methods & Materials This clinical trial was performed on 90 patients undergoing abdominal operation at 15Khordad Hospital, in 2017. The study patients were assigned to the intervention and control groups by permuted block randomization method (n=45/group). The study instrument was the Spielberger State-Trait Anxiety Inventory (STAI). The STAI was completed before and after conducting the intervention in both study groups. The obtained data were analyzed by SPSS using descriptive statistics, Student’s t-test, Paired Samples t-test, and Chi-squared test at a significance level of P0.05); however, after the intervention, there was a significant difference between the study groups in terms of apparent and total anxiety (P0.05). Conclusion Aromatherapy with rose is effective in decreasing the apparent anxiety of patients before surgery. Thus, it is recommended to be used as a complementary, inexpensive, and non-invasive treatment at healthcare centers.

21 September 2019 in hormozgan medical journal
Verified
Journal Article
Open access
PDF file
MMMahdi Basiri Moghadam
Mahdi Basiri Moghadam
SKShahla Khosravan
Shahla Khosravan
LSLeila Sadeghmoghadam
Leila Sadeghmoghadam
ANAmirreza Nasirzadeh
Amirreza Nasirzadeh
NENajmeh Ebrahimi
Najmeh Ebrahimi
Background: Self-concept is among the most important factors influencing health, particularly during adolescent years. Mental health in adolescents, social adaptation, and healthy behaviors require coordination and adaptation with physical and mental changes resulting from this period. Objectives: The purpose of the present study was to determine the effect of the Roy adaptation model-based intervention on the self-concept of teenage girls. Methods: This quasi-experimental study was conducted in 2016 on 64 teenage girls with the available random sampling method; subjects were randomly assigned into control and intervention groups. For the intervention group, 12 weeks of intervention were performed as instruction and follow-up. Data were collected before and after intervention using personal information form and a researcher-made questionnaire, including 50 questions of self-concept in teenage girls based on the Roy adaptation model. The validity was examined by content validity, and the reliability was examined by internal consistency with the Cronbach’s alpha of 0.74. Finally, data were analyzed using SPSS 16, descriptive statistics (mean, standard deviation, frequency), and analytical tests (independent t-test, chi-square). The significance level was below 0.05. Results: The average age of participants was 14.2 ± 1.21. Average self-concept before intervention in the control group was 171.31 ± 11.95 and in the intervention group was 165.03 ± 17.82 where no significant difference existed (P = 0.10). Average self-concept after intervention on control group was 176.62 ± 12.18 and in the intervention group was 197.06 ± 10.09, where a significant difference existed (P < 0.001). The results of the independent t-test in research groups after intervention showed that the employment of the Roy adaptation model promoted the average self-concept in teenage girls (P < 0.001). Conclusions: Employment of the designed program, based on the Roy adaptation model, can promote the self-concept of girls regarding transformations during their adolescent years.

1 September 2019 in International Journal of Medical Reviews
Verified
Journal Article
Open access
PDF file
MZMohammad Zahedi
Mohammad Zahedi
ARAlireza Razavi
Alireza Razavi
MSMoosa Sajjadi
Moosa Sajjadi
ANAmirreza Nasirzadeh
Amirreza Nasirzadeh
Depression is considered as a factor causing significant disability, mortality and healthcare costs and The third leading cause of disability which affects about 840 million people around the world. There are some biological, psychological and environmental theories explaining the pathophysiology of depression, though the main reason is still unknown. Vitamin D as a unique neurosteroid hormone may have an important role in the improvement of depression. Although the relationship between vitamin D levels and depressive symptoms has been explored, the results are inconsistent. Evidences about the relationship between vitamin D deficiency and depression are in conflict. Many studies indicted that, taking vitamin D supplements can be considered as a useful interventions for depressed patients with vitamins deficiency . The current review study suggests that, higher vitamin D intake may be associated with a lower prevalence of depressive symptoms. Neurons and glia in many parts of the brain such as the cingulate cortex and hippocampus have vitamin D receptors. There are different brain process which vitamin D involved including; Neuroimmunomodulation, regulation of neurotrophic factors, neuroprotection, neuroplasticity and brain development are kinds of brain processes. This fact demonstrates that vitamin D might be associated with depression and its supplementation might play an significant role in depression and its treatment . International Journal of Medical Reviews (IJMR)

23 May 2020 in medRxiv
Verified
Preprint
Open access
PDF file
MZmohammad zahedi
mohammad zahedi
MYMohammad Yousefi
Mohammad Yousefi
MAMahdi Abounoori
Mahdi Abounoori
MMMohammad Malekan
Mohammad Malekan
FTFatemeh Tajik
Fatemeh Tajik
RAReza Alizadeh-Navaei
Reza Alizadeh-Navaei
Introduction:The outbreak of new coronavirus has become a global public health challenge. Given a consequential liver function, and the high risk of death coming from liver disorders, the assessment of Novel Coronavirus Disease on liver function is importance. Hence, we carried out this meta-analysis to heightening insight into the occult features of COVID 19, which is likely to affect liver function. Method:This study was performed using databases of Web of Science, Scopus, and PubMed. We considered English cross-sectional and case-series papers, which reported available findings on the association between liver injury and COVID-19 infection. We used the STATA v.11 and random effect model for data analysis. Result:In this present meta-analysis, 52 papers, including 8,463 COVID-19 patients, were studied. The prevalence of increased liver enzymes among the patients, including Alanine aminotransferase, Aspartate aminotransferase, were 30% and 21% in non-severe patients, respectively, which were 38% and 48% in severe patients. The prevalence of increasing C-reactive protein, Lactate dehydrogenase, D-dimer, and Bilirubin were 55%, 39%, 28%, and 10% in non-severe patients respectively, which were 78%, 75%, 79% and 17% in sever patients.The prevalence of liver toxicity as a complication of COVID-19 was 20%.Also patients who have severe condition are 5.54, 4.22, 4.96, 4.13 and 4.34 times more likely to have elevated CRP, ALT, AST, LDH, D-dimer enzymes retrospectively. Conclusion:Elevation of some liver markers were higher in patients with severe COVID-19 infection. All to gather, we assumed that abnormal liver markers could act as a prognostic factor for a better survey of COVID-19.